MX2011006400A - Metodos y composiciones basadas en circovirus porcino tipo 2 (pcv2) para el tratamiento de cerdos. - Google Patents
Metodos y composiciones basadas en circovirus porcino tipo 2 (pcv2) para el tratamiento de cerdos.Info
- Publication number
- MX2011006400A MX2011006400A MX2011006400A MX2011006400A MX2011006400A MX 2011006400 A MX2011006400 A MX 2011006400A MX 2011006400 A MX2011006400 A MX 2011006400A MX 2011006400 A MX2011006400 A MX 2011006400A MX 2011006400 A MX2011006400 A MX 2011006400A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- pcv
- pigs
- treatment
- based methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a métodos y composiciones para vacunar cerdos contra enfermedades asociadas con circovirus porcino tipo 2 (PCV2). En particular, la invención se refiere a vectores de expresión recombinante que permite la secreción o la expresión de membrana celular de una forma truncada de la proteína del cuadro 2 de lectura abierta (ORF2) de PCV2.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12255508P | 2008-12-15 | 2008-12-15 | |
PCT/AU2009/001616 WO2010068969A1 (en) | 2008-12-15 | 2009-12-14 | Pcv 2-based methods and compositions for the treatment of pigs |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2011006400A true MX2011006400A (es) | 2011-09-15 |
Family
ID=42240826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011006400A MX2011006400A (es) | 2008-12-15 | 2009-12-14 | Metodos y composiciones basadas en circovirus porcino tipo 2 (pcv2) para el tratamiento de cerdos. |
Country Status (14)
Country | Link |
---|---|
US (1) | US20100150959A1 (es) |
EP (1) | EP2376639A1 (es) |
JP (1) | JP2012511896A (es) |
KR (1) | KR20110123725A (es) |
CN (1) | CN102333876A (es) |
AR (1) | AR074678A1 (es) |
AU (1) | AU2009328622A1 (es) |
BR (1) | BRPI0923514A2 (es) |
CA (1) | CA2746340A1 (es) |
EA (1) | EA201170813A1 (es) |
MX (1) | MX2011006400A (es) |
SG (1) | SG172183A1 (es) |
TW (1) | TW201026850A (es) |
WO (1) | WO2010068969A1 (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA95602C2 (ru) | 2004-12-30 | 2011-08-25 | Берингер Ингельхейм Ветмедика, Инк. | Иммуногенная композиция цвс2 и способы приготовления такой композиции |
DK3127551T3 (da) | 2005-12-29 | 2020-10-12 | Boehringer Ingelheim Animal Health Usa Inc | Pcv2-immunogen-sammensætning til at mindske kliniske symptomer i grise |
EP1968630B1 (en) | 2005-12-29 | 2018-01-24 | Boehringer Ingelheim Vetmedica, Inc. | Multivalent pcv2 immunogenic compositions |
US20100129397A1 (en) | 2006-12-11 | 2010-05-27 | Boehringer Ingelheim Vetmedica, Inc. | Effective method of treatment of porcine circovirus and lawsonia intracellularis infections |
EP1941903A1 (en) | 2007-01-03 | 2008-07-09 | Boehringer Ingelheim Vetmedica Gmbh | Prophylaxis and treatment of PRDC |
EP1958644A1 (en) | 2007-02-13 | 2008-08-20 | Boehringer Ingelheim Vetmedica Gmbh | Prevention and treatment of sub-clinical pcvd |
CN101884787A (zh) * | 2010-07-22 | 2010-11-17 | 洛阳普莱柯生物工程有限公司 | 猪圆环病毒2型亚单位疫苗及其制备方法 |
CN102827289B (zh) * | 2012-08-30 | 2014-04-09 | 青岛蔚蓝生物股份有限公司 | 猪圆环病毒2型Cap蛋白和胸腺素α1融合蛋白及应用 |
CN102824634B (zh) * | 2012-09-14 | 2014-03-19 | 范红结 | 表达猪圆环病毒2型Cap蛋白的重组猪痘病毒载体疫苗及其制备方法 |
CN103920146A (zh) * | 2013-01-14 | 2014-07-16 | 普莱柯生物工程股份有限公司 | 猪圆环病毒ⅱ型与猪伪狂犬病二联疫苗及其制备方法和应用 |
EP2789346A1 (en) | 2013-04-11 | 2014-10-15 | CEVA Santé Animale SA | Fusion polypeptides and vaccines |
WO2014187822A1 (en) * | 2013-05-22 | 2014-11-27 | Boehringer Ingelheim Espana, S.A. | Method for the reduction of pcv-2 in a herd of swine |
CN104031925A (zh) * | 2014-02-24 | 2014-09-10 | 福州大北农生物技术有限公司 | 优化的猪圆环病毒orf2基因的nls序列 |
CN104017813A (zh) * | 2014-06-03 | 2014-09-03 | 斯澳生物科技(苏州)有限公司 | 截短的pcv2型衣壳蛋白orf2病毒样颗粒及其制备方法 |
US10767185B2 (en) * | 2015-12-28 | 2020-09-08 | Agricultural Technology Research Institute | Method of preparing porcine circovirus type 2 capsid protein and pharmaceutical composition comprising same |
EP3254692A1 (en) | 2016-06-10 | 2017-12-13 | Ceva Sante Animale | Multivalent recombinant spv |
CN106399350B (zh) * | 2016-09-07 | 2020-02-21 | 复旦大学 | 一种猪圆环病毒ii型病毒样颗粒疫苗及其制备方法 |
HUE064720T2 (hu) | 2017-10-17 | 2024-04-28 | Intervet Int Bv | PCV2B ORF2 protein rekombináns expressziója rovarsejtekben |
GB2574609A (en) * | 2018-06-11 | 2019-12-18 | Univ Cape Town | Plant produced porcine circovirus pseudovirion |
PE20211141A1 (es) * | 2019-12-19 | 2021-06-25 | Farm Veterinarios S A C | Salmonella enteritidis recombinante y su uso como vacuna porcina |
CN112834744A (zh) * | 2020-12-31 | 2021-05-25 | 天津瑞普生物技术股份有限公司 | 一种猪群体内腺病毒3型中和抗体阳性率的elisa试剂盒及其检测方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5831023A (en) * | 1982-11-01 | 1998-11-03 | Genentech, Inc. | Recombinant animal interferon polypeptides |
US5151267A (en) * | 1988-07-15 | 1992-09-29 | University Of Saskatchewan | Bovine herpesvirus type 1 polypeptides and vaccines |
AUPO856097A0 (en) * | 1997-08-14 | 1997-09-04 | Commonwealth Scientific And Industrial Research Organisation | Vector |
FR2772047B1 (fr) * | 1997-12-05 | 2004-04-09 | Ct Nat D Etudes Veterinaires E | Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection |
FR2789695B1 (fr) * | 1999-02-11 | 2003-03-07 | Merial Sas | Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs |
US6852705B2 (en) * | 2000-01-21 | 2005-02-08 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
CN1769434A (zh) * | 2005-08-30 | 2006-05-10 | 广东省农业科学院兽医研究所 | 一种猪圆环病毒2型重组腺病毒及其构建方法和应用 |
BRPI0714932A2 (pt) * | 2006-07-28 | 2013-05-21 | Commw Scient Ind Res Org | mÉtodos e composiÇÕes para aumento do tropismo tecidual de vetores adenovirais recombinantes |
CN101092631B (zh) * | 2007-05-31 | 2010-04-14 | 华中农业大学 | 一种修饰的猪圆环病毒2型orf2基因及应用 |
-
2009
- 2009-11-19 US US12/621,607 patent/US20100150959A1/en not_active Abandoned
- 2009-12-10 TW TW098142364A patent/TW201026850A/zh unknown
- 2009-12-14 JP JP2011539853A patent/JP2012511896A/ja not_active Withdrawn
- 2009-12-14 EP EP09832698A patent/EP2376639A1/en not_active Withdrawn
- 2009-12-14 WO PCT/AU2009/001616 patent/WO2010068969A1/en active Application Filing
- 2009-12-14 EA EA201170813A patent/EA201170813A1/ru unknown
- 2009-12-14 SG SG2011043932A patent/SG172183A1/en unknown
- 2009-12-14 MX MX2011006400A patent/MX2011006400A/es not_active Application Discontinuation
- 2009-12-14 CN CN2009801567312A patent/CN102333876A/zh active Pending
- 2009-12-14 BR BRPI0923514A patent/BRPI0923514A2/pt not_active Application Discontinuation
- 2009-12-14 AU AU2009328622A patent/AU2009328622A1/en not_active Abandoned
- 2009-12-14 CA CA2746340A patent/CA2746340A1/en not_active Abandoned
- 2009-12-15 AR ARP090104893A patent/AR074678A1/es unknown
-
2010
- 2010-01-07 KR KR1020117016343A patent/KR20110123725A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BRPI0923514A2 (pt) | 2019-08-20 |
CN102333876A (zh) | 2012-01-25 |
WO2010068969A1 (en) | 2010-06-24 |
AU2009328622A1 (en) | 2011-07-07 |
AR074678A1 (es) | 2011-02-02 |
EA201170813A1 (ru) | 2012-01-30 |
US20100150959A1 (en) | 2010-06-17 |
KR20110123725A (ko) | 2011-11-15 |
EP2376639A1 (en) | 2011-10-19 |
TW201026850A (en) | 2010-07-16 |
JP2012511896A (ja) | 2012-05-31 |
SG172183A1 (en) | 2011-07-28 |
CA2746340A1 (en) | 2010-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2011006400A (es) | Metodos y composiciones basadas en circovirus porcino tipo 2 (pcv2) para el tratamiento de cerdos. | |
GB0712160D0 (en) | Methods and compositions in the treatment of procine circoviral infection | |
PH12014502525A1 (en) | Multivalent pcv2 immunogenic compositions and methods of producing such compositions | |
MY152149A (en) | Prevention and treatment of sub-clinical pcvd | |
UA100502C2 (ru) | Лечение prdc с применением антигена pcv2 | |
MY171300A (en) | Pharmaceutical composition | |
MX2009010492A (es) | Elementos de vector de expresion recombinante (reves) para mejorar la expresion de proteinas recombinantes en celulas huesped. | |
IN2012DN00338A (es) | ||
MX2010008206A (es) | Metodos y composiciones que utilizan polipeptidos de fusion de klotho-fgf. | |
WO2009151907A3 (en) | Compositions and methods for using cells to treat heart tissue | |
MX2012011543A (es) | Tratamiento de sarcoidosis empleando celulas madre placentarias. | |
NZ593474A (en) | Compositions and methods for treatment of celiac disease | |
WO2011017440A3 (en) | Implanting organ ports | |
MY151051A (en) | Vaccination against dengue virus infection | |
UA95458C2 (ru) | Вакцина против pcv-2 у mda-положительных поросят | |
ES2585328T3 (es) | Variantes no lipidadas de antígenos ORF2086 de Neisseria meningitidis | |
ES2622087T3 (es) | Vacuna recombinante contra paramyxovirus aviar y procedimiento de fabricación y utilización de la misma | |
WO2008124646A3 (en) | Use of amyloid proteins as vaccine scaffolds | |
AR063606A1 (es) | Estabilizacion de vacunas mediante liofilizacion | |
MY166537A (en) | Human monoclonal antibody with specificity for dengue virus serotype 1 e protein and uses thereof | |
MX352641B (es) | Vacuna contra pcv2 basada en peptidos de diseño. | |
WO2009152147A3 (en) | Compositions and methods for dengue virus (dv) treatment and vaccination | |
WO2009137778A3 (en) | Methods and compositions for genetically engineering clostridia species | |
MD4481B1 (ro) | Herpesvirus recombinant Koi (KHV) şi vaccin pentru profilaxia bolii cauzate de KHV | |
UA114286C2 (uk) | Спосіб лікування staphylococcus aureus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |